Skip to content

Advertisement

  • Research article
  • Open Access
  • Open Peer Review

Hypocholesterolemia is an independent risk factor for depression disorder and suicide attempt in Northern Mexican population

  • 1,
  • 1,
  • 1,
  • 2,
  • 1,
  • 1,
  • 3,
  • 4,
  • 1,
  • 5 and
  • 1, 6Email author
BMC PsychiatryBMC series – open, inclusive and trusted201818:7

https://doi.org/10.1186/s12888-018-1596-z

  • Received: 5 July 2017
  • Accepted: 8 January 2018
  • Published:
Open Peer Review reports

Abstract

Background

Cholesterol has been associated as a risk factor for cardiovascular disease. Recently, however, there is growing evidence about crucial requirement of neuron membrane cholesterol in the organization and function of the 5-HT1A serotonin receptor. For this, low cholesterol level has been reported to be associated with depression and suicidality. However there have been inconsistent reports about this finding and the exact relationship between these factors remains controversial. Therefore, we investigated the link between serum cholesterol and its fractions with depression disorder and suicide attempt in 467 adult subjects in Mexican mestizo population.

Methods

Plasma levels of total cholesterol, triglycerides, and high-density lipoprotein cholesterol (HDL-c) and low density lipoprotein cholesterol (LDL-c) were determined in 261 MDD patients meeting the DSM-5 criteria for major depressive disorder (MDD), 59 of whom had undergone an episode of suicide attempt, and 206 healthy controls.

Results

A significant decrease in total cholesterol, LDL-cholesterol, VLDL-cholesterol and triglyceride serum levels was observed in the groups of MDD patients and suicide attempt compared to those without suicidal behavior (p < 0.05). After adjusting for covariates, lower cholesterol levels were significantly associated with MDD (OR 4.229 CI 95% 2.555 – 7.000, p<.001) and suicide attempt (OR 5.540 CI 95% 2.825 – 10.866, p<.001)

Conclusions

These results support the hypothesis that lower levels of cholesterol are associated with mood disorders like MDD and suicidal behavior. More mechanistic studies are needed to further explain this association.

Keywords

  • Suicide attempt
  • depression
  • cholesterol

Background

Suicide is one of the most disastrous outcomes of psychiatric disorders [1]. It is a significant public health problem and is one of the leading causes of death worldwide [24]. In Mexico the rate of suicide is a current health problem that is accentuated by the fact that it is a country with an emerging market economy. In recent years, Mexico has presented an increase in its suicide rate. For example, between 2000 and 2014 there was an increase in the suicide rate from 3.5 to 5.2 cases per 100,000 inhabitants (http://bibliodigitalibd.senado.gob.mx/handle/123456789/3181) [5].

Suicidal behavior includes a wide spectrum of behaviors, such as completed suicides, high-lethality suicide attempts, and low-lethality suicide attempts [6, 7]. Although roughly 60% of all suicides occur in the context of depressive disorders [7, 8] it is still challenging for clinicians to predict suicide risk in patients with depression. For this reason, increased attention has been paid to potential biomarkers for suicide in patients with major depressive disorder (MDD) and suicidal behavior [1, 9].

Many studies have confirmed that biological markers might be linked to suicidality, among which serum lipid levels might play an important role [2, 1012]. However, there has been considerable controversy about the association between serum lipid levels and suicidality. Some human studies showed that suicide attempters had lower cholesterol levels [2, 11, 13, 14]others reported positive associations between cholesterol and completed suicide[2, 1517]and some others indicated that there was no evidence for an association between serum cholesterol and suicidality [18, 19].Although the mechanism behind hypocholesterolemia and suicide has not been clearly defined, previous studies have suggested that altered cholesterol at synaptic lipid rafts may cause a reduction in serotonin communication [2].

In the Mexican population, very few studies have examined the association between serum lipid levels and the presence of depression and suicide attempt, and none have reported the frequency of hypocholesterolemia in depressed patients and suicide attempters. Here, we hypothesized that: 1) serum lipid levels are reduced in subjects with depression and suicide attempt; 2) Hypocholesterolemia is a risk factor associated with depression and suicide attempt.

Methods

Study population

After the approval of protocol by Research and Ethics Committee of the General Hospital 450 (No. 12/0306-2015), a case-control study was conducted with 261 MDD adult patients, 59 of these also had a recent episode of suicide attempt and 206 healthy adult volunteer controls of both genders; all subjects provided informed consent. Study subjects were recruited from the Mental Health Hospital “Dr. Miguel Valle Bueno” (Secretary of Health) and psychiatry service of the General Hospital 450 (Secretary of Health) and General Hospital “Dr. Santiago Ramón y Cajal” (ISSSTE), in Durango City, Mexico, from June2015to December 2016.

MDD diagnosis was made by trained psychiatrists according to DSM-5 criteria. We defined suicide attempt as "a non-fatal, self-directed, potentially injurious behavior with an intent to die as a result of the behavior" as defined by the Center for Disease Control and Prevention (https://www.cdc.gov/violenceprevention/suicide/definitions.html) [20]. For our recruitment, we considered only participants that required hospitalization.Subjects in the case group were matched with subjects in the control group based on age, sex and body mass index (BMI).The latter, in order to exclude nutritional state as a confounding factor and due to previous association between BMI and cholesterol levels. [21]. Control subjects were apparently healthy persons without any symptoms or signs of MDD based on a clinical examination at inclusion. Use of lipid lowering drugs, such as statins was considered a confounding factor due to the diverse effects it may have on cellular mediation of inflammation and immunity [22] in conjunction with its known effect on depression [23] and was, therefore, an exclusion criterion. Lastly, we excluded those with chronic diseases (hepatic disorders, diabetes mellitus, hypertension, cardiovascular disease) due to their association with dyslipidemia. [24, 25]

Lipid profile

Blood samples were obtained by venous puncture of all participants after an overnight fasting period. The lipid profiles were determined using the A15 Clinical Chemistry and Turbidimetry Systems (BioSystems) according to the manufacturer’s instructions. The level of serum lipids was evaluated based on total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C) and triglycerides (TG).Hypocholesterolemia was defined as a total cholesterol concentration of less than 150 mg/dl.

Statistical Analyses

Numerical data were presented as mean±standard deviation (SD). Categorical variables were presented as proportions. Differences between the two case groups (MDD and MDD associated with suicide attempt) and control group (healthy subjects) were estimated using ANOVA (Kruskall Wallis test for skewed data) for numerical variables with an additional Bonferroni post-hoc test, and the chi-squared test for categorical variables. Additionally, our analysis was stratified by sex and logistic regression analysis was performed to determine the association between hypocholesterolemia (independent variable) and the presence of depression and suicide attempt (dependent variables). Values of p<0.05 were considered statistically significant. The Statistical Package for the Social Sciences (SPSS) for Windows version 21.0 (SPSS Inc., Chicago, IL) was used for data management and statistical analysis. Odds ratio (OR) and 95% confidence interval (95%CI) were determined, while p value <0.05 defined the statistical significance.

Results

Clinical characteristics and laboratory parameters of the 467 enrolled subjects are shown in Table 1. The comparative analysis of the serum lipid levels between the study groups showed significant differences in the total cholesterol, LDL-cholesterol, VLDL-cholesterol, triglycerides serum levels and, hypocholesterolemia frequency (p<0.05). No significant difference in HDL levels were observed between groups.
Table 1

Mean cholesterol levels and hypocholesterolemia frequency according to mental impairment categories

 

Healthy subjects

MDD

MDD associated w/suicide attempt

P value

n

206

202

59

--

Age, years

36.8 ± 6.6

37.3 ± 10.0

35.2 ± 10.5

0.363

Females / Males, n (%)

166 (80.5) /40 (19.5)

169 (83.7) /35 (16.3)

42 (71.2) /17 (28.8)

0.139

Obesity frequency (IMC>30 kg/m2), n (%)

55 (26.8)

63 (32)

15 (25.4)

0.431

Total cholesterol serum level, mg/dl

172.5 ± 25.3

167.9± 45.1

152.2 ± 39.0

<.001‡,*,†

HDL cholesterol serum level, mg/dl

46.0 ± 11.6

43.8 ± 14.5

46.0± 18.7

0.198

LDL cholesterol serum level, mg/dl

96.7 ± 29.4

84.0 ± 39.5

76.9 ± 32.5

0.014*

VLDL cholesterol serum level, mg/dl

28.9± 14.8

41.2± 23.0

37.6± 21.3

<.001‡,†

Triglyceridesserum level, mg/dl

142.7 ± 87.1

208.3± 119.7

172.8 ± 88.1

<.001‡,*,†

Hypocholesterolemia frequency (<150 mg/dl), n (%)

28 (13.6)

79 (38.2)

29 (49.2)

<.001

MDD Major depression disorder

Values are mean ± standard deviation

*Statistically significant difference between Healthy subjects and MDD associated with suicide attempt

Statistically significant difference between MDD and MDD associated with suicide attempt

Statistically significant difference between Healthy subjects and MDD

Post-hoc analysis between the two groups comprised of patients with MDD with suicide attempt (p<0.001) and MDD only (p<0.001) showed significantly lower total cholesterol levels compared to the control group. Also, patients with MDD who were associated with suicide attempt had significantly lower total cholesterol levels compared with MDD only (p 0.016).

LDL levels were lower in the MDD associated with suicide attempt group with respect to the control group (p 0.013). Subjects with depression presented higher VLDL (p<0.001) and triglyceride levels (p<0.001) compared with healthy controls. Similarly, subjects with depression presented higher VLDL (p 0.043) and triglyceride levels (p 0.039) compared with MDD with suicide attempt. The frequency of hypocholesterolemia was significantly higher in the MDD and MDD with suicide attempt groups compared with the control group (p<0.001).

A subgroup analysis by gender was performed in order to separately assess the magnitude of the association between lipid serum levels in men and women with MDD and suicide attempt (Table 2). Both, men and women showed significantly lower total cholesterol levels in subjects with MDD associated with suicide attempt compared with the control group (p<0.05). However, only in women, did we observe a significant difference between the MDD-only group versus the control group. No such relationship was seen in males. The comparative analysis of the hypocholesterolemia frequency between the study groups showed significant differences in both genders (p<0.05).
Table 2

Analysis by gender of clinical characteristics and laboratory parameters

 

Male

p value

Female

p value

Healthy subjects

MDD

MDD associated w/suicide attempt

Healthy subjects

MDD

MDD associated w/suicide attempt

n

40

36

17

 

166

171

42

 

Age, years

38.1 ± 6.1

35.8 ± 10.5

37.3 ± 11.9

0.592

36.5 ± 6.7

37.5 ± 10.0

34.3 ± 9.9

0.133

Obesity frequency (IMC>30 kg/m2), n (%)

10 (25)

6 (17.1)

3 (17.6)

0.664

45 (27.3)

57 (34.8)

12 (28.6)

0.322

Total cholesterol serum level, mg/dl

182.5 ± 42.5

164.8 ± 48.6

140.2 ± 32.1

0.002 ‡,*

170.1 ± 18.4

168.5 ± 44.4

157.1 ± 40.8

0.017*

HDL cholesterol serum level, mg/dl

46.4 ± 14.5

41.7 ± 15.8

44.1 ± 12.4

0.566

45.8 ± 10.2

44.2 ± 14.2

46.8 ± 20.9

0.301

LDL cholesterol serum level, mg/dl

100.8 ± 35.9

71.2 ± 37.2

71.7 ± 24.5

0.011

94.8 ± 26.2

86.7 ± 39.5

78.9 ± 35.3

0.165

VLDL cholesterol serum level, mg/dl

30.9 ± 17.0

55.4 ± 33.4

29.8 ± 10.1

0.002 ‡,†

28.1 ± 13.9

38.1 ± 18.9

34.9 ± 18.7

0.004

Triglycerides serum level, mg/dl

137.7 ± 66.9

277.1 ± 167.2

157.6 ± 60.2

<.001‡,†

143.9 ± 91.4

193.7 ± 101.8

179.0 ± 97.2

<.001‡,*

Hypocholesterolemia frequency (<150 mg/dl), n (%)

8 (20)

17 (47.2)

9 (52.9)

0.015

20 (12)

62 (36.3)

20 (47.6)

<.001

Values are mean ± standard deviation

*Statistically significant difference between Healthy subjects and MDD associated with suicide attempt

†Statistically significant difference between MDD and MDD associated with suicide attempt

‡Statistically significant difference between Healthy subjects and MDD

A bivariate logistic regression using data matched on age, sex, and BMI showed a statistically significant association between hypocholesterolemia and MDD (OR 4.229 CI 95% 2.555 – 7.000, p< 0.001). In the same way, a statistically significant association between hypocholesterolemia and suicide attempt was observed (OR 5.540 CI 95% 2.825 – 10.866, p<0.001). Additionally, triglycerides were analyzed and we found the following Odds Ratios and 95% Confidence Intervals: for hypertriglyceridemia in MDD [3.528 (2.326-5.352); p<0.001]; for hypertriglyceridemia in MDD with suicide attempt [2.626 (1.411-4.885); p=0.002]. Upon further analysis, no significant association in the other variables.

Discussion

Here, we show that lower serum cholesterol levels are linked with MDD and suicide attempt. Age and sex-adjusted analyses showed a clear association between serum cholesterol levels and the risk of depression and suicide attempt.

Previously, some studies have also shown an association between low cholesterol and increased risk of death due to injuries or suicide [2, 9, 2629], but not in other reports [1, 3033], even elevated cholesterol levels have been associated with suicide mortality in other studies [15, 33].

In Mexican subjects, there is only one research paper that has examined the possible link with hypocholesterolemia and suicide attempt in subjects with depression [34]. This study found no difference in lipid profiles between patients who had attempted suicide and those who had not. However, these authors studied only 33 patients with a major depressive episode (moderate to severe) comparing 18 subjects who had attempted suicide versus subjects who had never attempted suicide.

Although there is evidence of a link between low serum cholesterol levels and suicide in patients with depression [35, 36], the mechanism that may link serum lipids with suicidality is still unclear. It has been established that nearly all brain cholesterol is produced in situ through de novo synthesis and that adequate prevention of its uptake from the bloodstream is provided by selectivity of the blood-brain barrier [3739]. Nonetheless, it is viable that decreased peripheral cholesterol in those individuals with psychiatric disorders occurs concurrently with cholesterol modifications that take place in distinct synaptic lipid rafts in neurons (by a common regulatory mechanism). This could produce the minimized activity of serotonergic communication and, consequently, give rise to instinctive responses and violent suicidal behavior [2, 40].

Cholesterol is the paramount constituent of cellular membranes in higher eukaryotes and is essential in membrane function and organization as well as dynamics and sorting. It is commonly found dispersed in a non-random form in specific areas (domains) in both biological and model membranes [4143]. These areas, often denominated as ‘lipid rafts’ [43, 44], are thought to be fundamental in the preservation of the structure and function of the membrane. However, describing the spatiotemporal resolution of these domains has turned out to be a difficult task [43, 45]. It has been suggested that these formations be membrane domains in which signaling from a neurotransmitter may arise via a group of receptors, such as serotonin1A (5-HT1A) receptor [46].

Previous studies demonstrated the imperative necessity of membrane cholesterol in the function and organization of the 5-HT1A receptor [45, 4752]. Results from additional studies showed that the fluidity of lipids considerably regulates the binding of serotonin (5-HT) in murine brain membranes. It is therefore expected that decreased levels of cholesterol would increase the fluidity of the cellular membrane. While, at the same time, minimal exposure of the 5-HT receptors would be found in the synaptic cleft [2, 53].

Reportedly, disturbance of rafts by cholesterol deficiency notably lowers agonist binding and coupling of G protein to 5-hydroxytryptamine 1A (5-HT1A) serotonin receptors in bovine hippocampal membranes [46, 47]. Serotonin1A receptors typify one of the most formidable, evolutionarily primitive, yet largely conserved families of seven transmembrane G protein-coupled receptors (GPCRs) that span the membrane [45, 54]. Also, serotonergic signaling constitutes an important part in the formation and regulation of a multitude of functions such as behavioral, cognitive, and developmental [45]. Moreover, studies have demonstrated that there is an association between decreased 5-HT activity and suicide [2, 55].

It is noteworthy to mention that recent studies described crystal structures of GPCRs, including serotonin1A receptor, that demonstrated structural proof of cholesterol binding sites [45, 56, 57].Currently, two conceivable pathways have been proposed by which membrane cholesterol could affect the structure and function of GPCRs: (i) by way of a direct/specific interaction with GPCRs, or (ii) via an indirect pathway by modifying the physical properties of the membrane in which the receptor is inserted, or as a result of an integration of both [45, 58].

About cholesterol levels and their relation to gender, our study showed that the decrease in total cholesterol levels occurred in both men and women. Other authors have reported a relationship between reduced cholesterol and suicidal tendencies only in males [13, 5962]. However, it is worth noting that additional studies on the association between gender and serum cholesterol have been unconvincing.

A lack of consistency between different published reports coupled with the fact that, to date, it has not been possible to identify a cholesterol threshold level capable of precipitating a psychiatric disorder, suggests the presence of a non-linear relationship.

The existence of reports in which depression has been associated with increased cholesterol levels would support this hypothesis. A possible explanation for this, proposed the involvement of monoamine oxidase (MAO). The aforementioned model studies associated hypercholesterolemia with depression in hypercholesterolemic mice via monoaminergic metabolism. Specifically, they reported increased monoamine oxidase (MAO) A and B activity in the hippocampus of mice [63, 64]. Thus providing one possible reason why elevated levels of cholesterol are able to produce depression much like decreased levels are able to, but via independent mechanisms.

Besides total cholesterol, other studies that investigated the link between triglycerides, HDL cholesterol and LDL cholesterol, observed contrasting results between different populations. Our results showed higher levels of triglycerides in subjects with MDD and MDD associated with suicide attempt. These findings do not coincide with data previously reported in 2015 that observed decreased levels of triglycerides in subjects with suicidal attempts [65]. However, other authors report conflicting findings, even suggesting a positive association between triglyceride levels and the risk of suicidal behavior [15]. Considering LDL cholesterol levels, our results coincide with the conclusions of a meta-analysis published in 2016, which included a total of 36 different studies and found overall association between lower LDL levels and depression [66]. With respect to VLDL levels, which were significantly higher in MDD versus healthy controls, it is worth noting that few studies report VLDL levels. Taking this into consideration, our result is different from the result reported in a previous study [67] that showed significantly lower levels while our results demonstrate higher levels. With respect to HDL cholesterol levels, our results did not demonstrate significant differences when comparing subjects with MDD, subjects with MDD associated with suicide attempt and the control group. This fact contrasts with previous studies in which significant differences in HDL cholesterol between subjects with attempted suicide and healthy controls were shown [59, 68].

Lastly, we found a significant association between elevated triglyceride levels versus MDD and MDD with suicide attempt. Our finding coincides with a previous study which found a correlation between depressive symptoms and triglyceride levels [69] and suggestions by others which postulate that high triglyceride levels are associated with Type A personality traits, such as hostility, anger and domineering attitudes [70].

Several limitations of this study deserve to be mentioned. First, because our study is based on a case-control design, temporality could be not inferred with certainty. Whether hypocholesterolemia is a risk factor for developing depression and suicide attempt or merely an associated epiphenomenon can not be assured with certainty; second, we did not measure 24 S-hydroxycholesterol levels, which is a peripheral biomarker of brain cholesterol metabolism. However, it is expected that reduction of total cholesterol would reduce 24 S-hydroxycholesterol [71]. Besides, we did not evaluate dietary intake; however, because subjects in the groups of the study were enrolled from the same socio-cultural and economic background, it is expected that customary diets were similarly distributed. Finally, an additional limitation of our study is that we did not analyze the cardiovascular risk associated with serum cholesterol concentrations. In the future, it will be important to profoundly analyze the contradictory results reported with regard to cholesterol's role in depression. [63, 64]. This would help to verify if cholesterol is, in fact, a viable biomarker for neuropsychiatric disorders. It is evident that these results may be extrapolated only to a population that is similar to our own with similar exclusion criteria. Strengths of our study include the inclusion of incident cases of suicide attempt, which is a recognized tool to minimize analysis bias in the cross-sectional studies; also, the exclusion of individuals with lipid-lowering drugs allows us to control the potential source of bias.

Conclusions

In conclusion, our results show that hypocholesterolemia is independently associated with depression and suicide attempt in adults of the Mexican population .This finding, if consistent in more studies in our population, could influence public health policies focused in the prevention of mental health disorders. Measuring cholesterol levels could be a minimally invasive, inexpensive and simple way to predict suicide risk in our population. The use of cholesterol levels as a biomarker would permit clinicians to efficiently obtain a laboratory result that, once combined with clinical evaluations and symptoms, could permit a more timely diagnosis. Additionally, it would be necessary to calculate the sensibility and specificity of this test in our population.

Abbreviations

CHOL: 

Cholesterol

HDL: 

High-density lipoprotein

LDL: 

Low-density lipoprotein

MDD: 

Major depressive disorder

VLDL: 

Very low-density lipoprotein

Declarations

Acknowledgements

We would like to thank the Department of Education from the Mental Health Hospital “Dr. Miguel Valle Bueno” (Secretary of Health) and Department of Psychiatry from General Hospital 450 (Secretary of Health) and General Hospital “Dr. Santiago Ramón y Cajal” (ISSSTE).

Funding

Materials used in the experimental stages were obtained through FOSISS CONACYT-2015 (Grant 261453). The funding body did not participate in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors' contributions

EMH and FCJ conceived and designed the experiments; MCC, EMM and MSM performed the experiments; OLL and JSP analyzed the data; OAC and MBS contributed analysis tools; FVA, JMH and EMM wrote the paper. All authors read and approved the final manuscript

Ethics approval and consent to participate

The protocol was approved by the Ethics Committee for Research of the General Hospital 450, Secretary of Health of Durango (No. 12/0306-2015). Informed consent was obtained from participants was in written form.

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Instituto de Investigación Científica, Universidad Juárez del Estado de Durango, Universidad S/N esquina Volantín Zona Centro CP 34000, Zip Code 34000 Av., Durango, Mexico
(2)
Hospital General 450, Servicios de Salud de Salud, Zip Code 34206, Durango, México
(3)
Departamento de Biotecnología, Universidad Autónoma Metropolitana, Ciudad de México, México, Zip Code 09340
(4)
Facultad de Ciencias Químicas, Universidad Juárez del Estado de Durango, Zip Code 34000, Durango, México
(5)
Unidad de Trastornos del Movimiento y Sueño (TMS), Hospital General Dr. Manuel Gea González, Zip Code 14080, Ciudad de México, México
(6)
Subdirección de Investigación en Salud, Servicios de Salud de Durango, Zip Code 34000., Durango, México

References

  1. Baek JH, Kang ES, Fava M, Mischoulon D, Nierenberg AA, Yu BH, et al. Serum lipids, recent suicide attempt and recent suicide status in patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2014;51:113–8. doi:10.1016/j.pnpbp.2014.01.018.View ArticlePubMedGoogle Scholar
  2. Wu S, Ding Y, Wu F, Xie G, Hou J, Mao P. Serum lipid levels and suicidality: a meta-analysis of 65 epidemiological studies. J Psychiatry Neurosci. 2016;41:56–69.View ArticlePubMedPubMed CentralGoogle Scholar
  3. Kay M. Suicide is leading cause of death in young Indian women, finds the international study. BMJ. 2013;346:f1900. doi:10.1136/bmj.f1900.View ArticlePubMedGoogle Scholar
  4. O’Connor E, Gaynes BN, Burda BU, Soh C, Whitlock EP. Screening for and treatment of suicide risk relevant to primary care: a systematic review for theU.S. Preventive Services Task Force. Ann Intern Med. 2013;158:741–54. doi:10.7326/0003-4819-158-10-201305210-00642.View ArticlePubMedGoogle Scholar
  5. Día Mundial para la Prevención del Suicidio. http://bibliodigitalibd.senado.gob.mx/handle/123456789/3181. Accessed 31 October 2017.
  6. Mann JJ. A current perspective of suicide and attempted suicide. Ann Intern Med. 2002;136:302–11.View ArticlePubMedGoogle Scholar
  7. Lee BH, Kim YK. Potential peripheral biological predictors of suicidal behavior in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35:842–7. doi:10.1016/j.pnpbp.2010.08.001.View ArticlePubMedGoogle Scholar
  8. Carlson GA, Rich CL, Grayson P, Fowler RC. Secular trends in psychiatric diagnoses of suicide victims. J Affect Disord. 1991;21:127–32.View ArticlePubMedGoogle Scholar
  9. Messaoud A, Mensi R, Mrad A, Mhalla A, Azizi I, Amemou B, et al. Is low total cholesterol levels associated with suicide attempt in depressive patients? Ann Gen. Psychiatry. 2017;16:20. doi:10.1186/s12991-017-0144-4.View ArticlePubMedPubMed CentralGoogle Scholar
  10. Asellus P, Nordstrom P, Jokinen J. Cholesterol and CSF 5-HIAA in attempted suicide. J Affect Disord. 2010;125:388–92. doi:10.1016/j.jad.2010.02.111.View ArticlePubMedGoogle Scholar
  11. Lee HJ, Kim YK. Serum lipid levels and suicide attempts. Acta Psychiatr Scand. 2003;108:215–21.View ArticlePubMedGoogle Scholar
  12. Huang TL. Serum lipid profiles in major depression with clinical subtypes, suicide attempts and episodes. J Affect Disord. 2005;86:75–9.View ArticlePubMedGoogle Scholar
  13. Diaz-Sastre C, Baca-Garcia E, Perez-Rodriguez MM, Garcia-Resa E, Ceverino A, Saiz-Ruiz J, et al. Low plasma cholesterol levels in suicidal males: a gender- and body mass index-matched case-control study of suicide attempters and nonattempters. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:901–5.View ArticlePubMedGoogle Scholar
  14. Kim YK, Lee HJ, Kim JY, Yoon DK, Choi SH, Lee MS. Low serum cholesterol is correlated to suicidality in a Korean sample. Acta Psychiatr Scand. 2002;105:141–8.View ArticlePubMedGoogle Scholar
  15. Brunner J, Bronisch T, Pfister H, Jacobi F, Höfler M, Wittchen HU. High cholesterol, triglycerides, and body-mass index in suicide attempters. Arch Suicide Res. 2006;10:1–9.View ArticlePubMedGoogle Scholar
  16. Fiedorowicz JG, Coryell WH. Cholesterol and suicide attempts: a prospective study of depressed inpatients. Psychiatry Res. 2007;152:11–20.View ArticlePubMedPubMed CentralGoogle Scholar
  17. De Leon J, Mallory P, Maw L, Susce MT, Perez-Rodriguez MM, Baca-Garcia E. Lack of replication of the association of low serum cholesterol and attempted suicide in another country raises more questions. Ann Clin Psychiatry. 2011;23:163–70.PubMedGoogle Scholar
  18. Deisenhammer EA, Kramer-Reinstadler K, Liensberger D, Kemmler G, Hinterhuber H, Fleischhacker WW. No evidence for an association between serum cholesterol and the course of depression and suicidality. Psychiatry Res. 2004;121:253–61.View ArticlePubMedGoogle Scholar
  19. Roy A, Roy M. No relationship between serum cholesterol and suicidal ideation and depression in African-American diabetics. Arch Suicide Res. 2006;10:11–4.View ArticlePubMedGoogle Scholar
  20. Violence Prevention. https://www.cdc.gov/violenceprevention/suicide/definitions.html. Accessed 14 Jan 2018.
  21. Shamai L, Lurix E, Shen M, Novaro GM, Szomstein S, Rosenthal R, et al. Association of body mass index and lipid profiles: evaluation of a broad spectrum of body mass index patients including the morbidly obese. Obes Surg. 2011;21:42–7. doi:10.1007/s11695-010-0170-7.View ArticlePubMedGoogle Scholar
  22. Bu DX, Griffin G, Lichtman AH. Mechanisms for the anti-inflammatory effects of statins. Curr Opin Lipidol. 2011;22:165–70. doi:10.1097/MOL.0b013e3283453e41.View ArticlePubMedGoogle Scholar
  23. Redlich C, Berk M, Williams LJ, Sundquist J, Sundquist K, Li X. Statin use and risk of depression: a Swedish national cohort study. BMC psychiatry. 2014;14:348. doi:10.1186/s12888-014-0348-y.View ArticlePubMedPubMed CentralGoogle Scholar
  24. Dalal JJ, Padmanabhan TNC, Jain P, Patil S, Vasnawala H, Gulati A. LIPITENSION: Interplay between dyslipidemia and hypertension. Indian J Endocrinol Metab. 2012;16:240. doi:10.4103/2230-8210.93742.View ArticlePubMedPubMed CentralGoogle Scholar
  25. Schofield JD, Liu Y, Rao-Balakrishna P, Malik RA, Soran H. Diabetes dyslipidemia. Diabetes Ther. 2016;7:203–19. doi:10.1007/s13300-016-0167-x.View ArticlePubMedPubMed CentralGoogle Scholar
  26. Muldoon MF, Manuck SB, Matthews KA. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. BMJ. 1990;301:309–14.View ArticlePubMedPubMed CentralGoogle Scholar
  27. Lindberg G, Råstam L, Gullberg B, Eklund GA. Low serum cholesterol concentration and short term mortality from injuries in men and women. BMJ. 1992;305:277–9.View ArticlePubMedPubMed CentralGoogle Scholar
  28. Neaton JD, Blackburn H, Jacobs D, Kuller L, Lee DJ, Sherwin R, et al. Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Arch Intern Med. 1992;152:1490–500.View ArticlePubMedGoogle Scholar
  29. Zureik M, Courbon D, Ducimetière P. Serum cholesterol concentration and death from suicide in men: Paris prospective study I. BMJ. 1996;313:649–51.View ArticlePubMedPubMed CentralGoogle Scholar
  30. Jacobs D, Blackburn H, Higgins M, Reed D, Iso H, McMillan G, et al. Report of the Conference on Low Blood Cholesterol: Mortality Associations. Circulation. 1992;86:1046–60.View ArticlePubMedGoogle Scholar
  31. Vartiainen E, Puska P, Pekkanen J, Tuomilehto J, Lönnqvist J, Ehnholm C. Serum cholesterol concentration and mortality from accidents, suicide, and other violent causes. BMJ. 1994;309:445–7.View ArticlePubMedPubMed CentralGoogle Scholar
  32. Apter A, Laufer N, Bar-Sever M, Har-Even D, Ofek H, Weizman A. Serum cholesterol, suicidal tendencies, impulsivity, aggression, and depression in adolescent psychiatric inpatients. Biol Psychiatry. 1999;46:532–41.View ArticlePubMedGoogle Scholar
  33. Tanskanen A, Vartiainen E, Tuomilehto J, Viinamäki H, Lehtonen J, Puska P. High serum cholesterol and risk of suicide. Am J Psychiatry. 2000;157:648–50.View ArticlePubMedGoogle Scholar
  34. Almeida-Montes LG, Valles-Sanchez V, Moreno-Aguilar J, Chavez-Balderas RA, García-Marín JA, Sotres JC, et al. Relation of serum cholesterol, lipid, serotonin and tryptophan levels to severity of depression and to suicide attempts. J Psychiatry Neurosci. 2000;25:371–7.PubMedPubMed CentralGoogle Scholar
  35. De Berardis D, Marini S, Piersanti M, Cavuto M, Perna G, Valchera A, et al. The Relationships between Cholesterol and Suicide: An Update. ISRN Psychiatry. 2012:387901. doi:10.5402/2012/387901.
  36. Park YM, Lee BH, Lee SH. The association between serum lipid levels, suicide ideation, and central serotonergic activity in patients with major depressive disorder. J Affect Disord. 2014;159:62–5. doi:10.1016/j.jad.2014.01.016.View ArticlePubMedGoogle Scholar
  37. Dietschy JM, Turley SD. Cholesterol metabolism in the brain. Curr Opin Lipidol. 2001;12:105–12.View ArticlePubMedGoogle Scholar
  38. Suzuki R, Lee K, Jing E, Biddinger SB, McDonald JG, Montine TJ, et al. Diabetes and insulin in regulation of brain cholesterol metabolism. Cell Metab. 2010;12:567–79. doi:10.1016/j.cmet.2010.11.006.View ArticlePubMedPubMed CentralGoogle Scholar
  39. Reiss AB, Siller KA, Rahman MM, Chan ES, Ghiso J, de Leon MJ. Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer’s disease. Neurobiol Aging. 2004;25:977–89.View ArticlePubMedGoogle Scholar
  40. Cantarelli MG, Tramontina AC, Leite MC, Gonçalves CA. Potential neurochemical links between cholesterol and suicidal behavior. Psychiatry Res. 2014;220:745–51. doi:10.1016/j.psychres.2014.10.017.View ArticleGoogle Scholar
  41. Mouritsen OG, Zuckermann MJ. What’s so special about cholesterol? Lipids. 2004;39:1101–13.View ArticlePubMedGoogle Scholar
  42. Mukherjee S, Maxfield FR. Membrane domains. Annu Rev Cell Dev Biol. 2004;20:839–66.View ArticlePubMedGoogle Scholar
  43. Jacobson K, Mouritsen OG, Anderson RGW. Lipid rafts: at a crossroad between cell biology and physics. Nat Cell Biol. 2007;9:7–14.View ArticlePubMedGoogle Scholar
  44. Lingwood D, Simons K. Lipid rafts as a membrane-organizing principle. Science. 2010;327:46–50. doi:10.1126/science.1174621.View ArticlePubMedGoogle Scholar
  45. Jafurulla M, Tiwari S, Chattopadhyay A. Identification of cholesterol recognition amino acid consensus (CRAC) motif in G-protein coupled receptors. Biochem Biophys Res Commun. 2011;404:569–73. doi:10.1016/j.bbrc.2010.12.031.View ArticlePubMedGoogle Scholar
  46. Allen JA, Halverson-Tamboli RA, Rasenick MM. Lipid raft microdomains and neurotransmitter signalling. Nat Rev Neurosci. 2007;8:128–40.View ArticlePubMedGoogle Scholar
  47. Pucadyil TJ, Chattopadhyay A. Cholesterol modulates the ligand binding and G-protein coupling to serotonin1A receptors from bovine hippocampus. Biochim Biophys Acta. 2004;1663:188–200.View ArticlePubMedGoogle Scholar
  48. Pucadyil TJ, Chattopadhyay A. Role of cholesterol in the function and organization of G-protein coupled receptors. Prog Lipid Res. 2006;45:295–333.View ArticlePubMedGoogle Scholar
  49. Pucadyil TJ, Chattopadhyay A. Cholesterol depletion induces dynamic confinement of the G-protein coupled serotonin1A receptor in the plasma membrane of living cells. Biochim Biophys Acta. 2007;1768:655–68.View ArticlePubMedGoogle Scholar
  50. Paila YD, Murty MR, Vairamani M, Chattopadhyay A. Signaling by the human serotonin1A receptor is impaired in cellular model of Smith-Lemli-Optiz Syndrome. Biochim Biophys Acta. 2008;1778:1508–16. doi:10.1016/j.bbamem.2008.03.002.View ArticlePubMedGoogle Scholar
  51. Paila YD, Chattopadhyay A. Membrane cholesterol in the function and organization of G-protein coupled receptors. Subcell Biochem. 2010;51:439–66. doi:10.1007/978-90-481-8622-8_16.View ArticlePubMedGoogle Scholar
  52. Shrivastava S, Pucadyil TJ, Paila YD, Ganguly S, Chattopadhyay A. Chronic cholesterol depletion using statin impairs the function and dynamics of human serotonin1A receptors. Biochemistry. 2010;49:5426–35. doi:10.1021/bi100276b.View ArticlePubMedGoogle Scholar
  53. Heron DS, Shinitzky M, Hershkowitz M, Samuel D. Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes. Proc Natl Acad Sci U S A. 1980;77:7463–7.View ArticlePubMedPubMed CentralGoogle Scholar
  54. Pucadyil TJ, Kalipatnapu S, Chattopadhyay A. The serotonin1A receptor: a representative member of the serotonin receptor family. Cell Mol Neurobiol. 2005;25:553–580.Google Scholar
  55. Asberg M, Träskman L, Thorén P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry. 1976;33:1193–7.View ArticlePubMedGoogle Scholar
  56. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, et al. High-resolution crystal structure of an engineered human β2-adrenergic G protein–coupled receptor. Science. 2007;318:1258–65.View ArticlePubMedPubMed CentralGoogle Scholar
  57. Hanson MA, Cherezov V, Griffith MT, Roth CB, Jaakola VP, Chien EY, et al. A specific cholesterol binding site is established by the 2.8 Å structure of the human β2-adrenergic receptor. Structure. 2008;16:897–905. doi:10.1016/j.str.2008.05.001.View ArticlePubMedPubMed CentralGoogle Scholar
  58. Paila YD, Chattopadhyay A. The function of G-protein coupled receptors and membrane cholesterol: specific or general interaction? Glycoconj J. 2009;26:711–20. doi:10.1007/s10719-008-9218-5.View ArticlePubMedGoogle Scholar
  59. Maes M, Smith R, Christophe A, Vandoolaeghe E, Van Gastel A, Neels H, et al. Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicide attempts: relationship with immune inflammatory markers. Acta Psychiatr Scand. 1997;95:212–21.View ArticlePubMedGoogle Scholar
  60. Bocchetta A, Chillotti C, Carboni G, Oi A, Ponti M, Del Zompo M. Association of personal and familial suicide risk with low serum cholesterol concentration in male lithium patients. Acta Psychiatr Scand. 2001;104:37–41.View ArticlePubMedGoogle Scholar
  61. Golier JA, Marzuk PM, Leon AC, Weiner C, Tardiff K. Low serum cholesterol level and attempted suicide. Am J Psychiatry. 1995;152:419–23.View ArticlePubMedGoogle Scholar
  62. Soeda S, Terao T, Iwata N, Abe H, Uchida K, Nakamura J. Mental effect of cholesterol in males: protective effect? J Affect Disord. 2006;91:139–44. doi:10.1016/j.jad.2005.10.012.View ArticlePubMedGoogle Scholar
  63. Svensson T, Inoue M, Sawada N, Charvat H, Mimura M, Tsugane S. High serum total cholesterol is associated with suicide mortality in Japanese women. Acta Psychiatr Scand. 2017;136:259–68. doi:10.1111/acps.12758.View ArticlePubMedGoogle Scholar
  64. Engel DF, de Oliveira J, Lopes JB, Santos DB, Moreira ELG, Farina M, et al. Is there an association between hypercholesterolemia and depression? Behavioral evidence from the LDLr−/− mouse experimental model. Behav Brain Res. 2016;311:31–8. doi:10.1016/j.bbr.2016.05.029.View ArticlePubMedGoogle Scholar
  65. da Graça Cantarelli M, Nardin P, Buffon A, Eidt MC, Godoy LA, Fernandes BS, et al. Serum triglycerides, but not cholesterol or leptin, are decreased in suicide attempters with mood disorders. J Affect Disord. 2015;172:403–9. doi:10.1016/j.jad.2014.10.033.View ArticlePubMedGoogle Scholar
  66. Persons JE, Fiedorowicz JG. Depression and serum low-density lipoprotein: A systematic review and meta-analysis. J Affect Disord. 2016;206:55–67. doi:10.1016/j.jad.2016.07.033.View ArticlePubMedGoogle Scholar
  67. Kale AB, Kale SB, Chalak SS, Tankhiwale SR, Bang G, Agrawal M, Kaple M. Lipid parameters–significance in patients with endogenous depression. J Clin Diagn Res. 2014;8:17–9. doi:10.7860/JCDR/2014/4059.3911.PubMedPubMed CentralGoogle Scholar
  68. Zhang J, McKeown RE, Hussey JR, Thompson SJ, Woods JR, Ainsworth BE. Low HDL cholesterol is associated with suicide attempt among young healthy women: the Third National Health and Nutrition Examination Survey. J Affect Disord. 2005;89:25–33.View ArticlePubMedGoogle Scholar
  69. Huang TL, Chen JF. Lipid and lipoprotein levels in depressive disorders with melancholic feature or atypical feature and dysthymia. Psychiatry Clin Neurosci. 2004;58:295–9.View ArticlePubMedGoogle Scholar
  70. Tzavellas E, Karaiskos D, Paparrigopoulos T. Triglycerides, Depression, and Risk of Ischemic Stroke. Jama. 2009;3011338–1339. doi: 10.1001/jama.2009.410.
  71. Bretillon L, Lütjohann D, Ståhle L, Widhe T, Bindl L, Eggertsen G, et al. Plasma levels of 24S-hydroxycholesterol reflect the balance between cerebral production and hepatic metabolism and are inversely related to body surface. J Lipid Res. 41:840–5.Google Scholar

Copyright

Advertisement